Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roujin Formula for Fibromyalgia
NCT06285045Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Oct 2018
- Primary completion
- Aug 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of Roujin Formula in fibromyalgia syndrome (FMS) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Revised Fibromyalgia Impact Questionnaire at 12 weeks and Visual Analogue Scale at 12 weeks. Started Oct 2018; status: completed.
02
Drugs
Roujin Formula
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT06285045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06285045.